Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Treatment Patterns and Outcomes of DLBCL after Failure of Front-Line Immunochemotherapy

Umar Farooq, MD, Matthew J Maurer, MS, Stephen M Ansell, MD, PhD, Tasha Lin, MD, Grzegorz S. Nowakowski, MD, Luis Porrata, MD, David J. Inwards, MD, William Macon, MD, Syrbu Sergei, MD, James Cerhan, MD PhD, Thomas E. Witzig, MD, Brian K Link, MD, Thomas M. Habermann, MD, Carrie A. Thompson, MD

Blood (2015) 126 (23): 2683.

https://doi.org/10.1182/blood.V126.23.2683.2683

Published: 2015

Journal Articles

Study of the Subclonal Mutations in Primary Diffuse Large B-Cell Lymphoma

Yan Asmann, PhD, Vivekananda Sarangi, MS, Chen Wang, PhD, Matthew J Maurer, MS, Stephen Ansell, MD PhD, Andrew L Feldman, MD, Grzegorz S. Nowakowski, MD, Thomas M. Habermann, MD, Anne J. Novak, PhD, Susan L. Slager, PhD, Brian K Link, MD, James Cerhan, MD PhD

Blood (2015) 126 (23): 131.

https://doi.org/10.1182/blood.V126.23.131.131

Published: 2015

Journal Articles

Disease Progression and Complications Are the Main Cause of Death in Patients with Chronic Lymphocytic Leukemia (CLL) Independent of Age and Comorbidities at Diagnosis

Paolo Strati, MD, Kari Chaffee, Sara Achenbach, Susan M. Schwager, Timothy G. Call, MD, Neil E. Kay, MD, James Cerhan, MD PhD, Susan L. Slager, PhD, Tait D. Shanafelt, MD

Blood (2015) 126 (23): 5265.

https://doi.org/10.1182/blood.V126.23.5265.5265

Published: 2015

Journal Articles

Incidence and Outcomes of Treatment Refractory Diffuse Large B-Cell Lymphoma in the Immunochemotherapy Era

Matthew J Maurer, MS, Carrie A. Thompson, MD, Umar Farooq, MD, Tasha Lin, MD, Grzegorz S. Nowakowski, MD, Yi Lin, MD PhD, Ivana Micallef, MD, Anne Novak, PhD, William Macon, MD, Sergei Syrbu, MD, James Cerhan, MD PhD, Thomas E. Witzig, MD, Thomas M. Habermann, MD, Stephen Ansell, MD PhD, Brian K Link, MD

Blood (2015) 126 (23): 3992.

https://doi.org/10.1182/blood.V126.23.3992.3992

Published: 2015

Journal Articles

Natural History of Central Nervous System Relapse in Diffuse Large B Cell Lymphoma in the Immunochemotherapy Era

Gita Thanarajasingam, MD, Matthew J Maurer, MS, Umar Farooq, MD, Patrick B. Johnston, MD PhD, Carrie Thompson, MD, Stephen Ansell, MD PhD, Luis Porrata, MD, William Macon, MD, Sergei Syrbu, MD, James Cerhan, MD PhD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, Brian K Link, MD, Grzegorz S. Nowakowski, MD

Blood (2015) 126 (23): 1456.

https://doi.org/10.1182/blood.V126.23.1456.1456

Published: 2015

Journal Articles

Event-Free Survival at 12 Months and Subsequent Overall Survival in Patients with Peripheral T-Cell Lymphoma

Matthew J Maurer, MS, Fredrik Ellin, MD MSc, James Cerhan, MD PhD, Stephen Ansell, MD PhD, Brian K Link, MD, Mats Jerkeman, MD PhD, Karin E Smedby, MD PhD, Carrie A. Thompson, MD, William Macon, MD, Sergei Syrbu, MD, Susan L. Slager, PhD, Thomas E. Witzig, MD, Thomas M. Habermann, MD, Thomas Relander, MD PhD, Andrew L Feldman, MD

Blood (2015) 126 (23): 1501.

https://doi.org/10.1182/blood.V126.23.1501.1501

Published: 2015

Journal Articles

Investigation of CLL-Susceptibility Loci with Monoclonal B-Cell Lymphocytosis (MBL) Risk and Confirmation of Recently Reported CLL-Susceptibility Loci

Blood (2010) 116 (21): 2443.

https://doi.org/10.1182/blood.V116.21.2443.2443

Published: 2010

Journal Articles

Vitamin D Insufficiency and Prognosis In Chronic Lymphocytic Leukemia (CLL)

Tait Shanafelt, MD, Matthew Drake, Matthew Mauer, Cristine Allmer, Kari Rabe, Susan Slager, PhD, George Weiner, MD, Timothy Call, MD, Brian Link, Clive S. Zent, MD, Neil E. Kay, Curtis Hanson, Thomas E. Witzig, MD, James Cerhan, MD, PhD

Blood (2010) 116 (21): 2408.

https://doi.org/10.1182/blood.V116.21.2408.2408

Published: 2010

Journal Articles

Monoclonal and Polyclonal Serum Free Light Chains and Clinical Outcome In Chronic Lymphocytic Leukemia

Matthew J Maurer, James Cerhan, MD, PhD, Jerry A Katzmann, PhD, Brian Link, Cristine Allmer, Clive S. Zent, MD, Timothy Call, MD, Kari Rabe, Curtis A. Hanson, MD, Neil E. Kay, Susan Slager, PhD, Thomas E. Witzig, MD, Tait Shanafelt, MD

Blood (2010) 116 (21): 2409.

https://doi.org/10.1182/blood.V116.21.2409.2409

Published: 2010

Journal Articles

Does An Anthracycline Make a Difference for Follicular Lymphoma (FL) Grade 3? Patterns of Care and Treatment Outcomes of Grade 3 FL From the National LymphoCare Study (NLCS)

Christopher R Flowers, MD, MS, Michael Taylor, PharmD, PhD, Michelle Byrtek, PhD, Jamie H. Hirata, PharmD, James Cerhan, MD, PhD, John Hainsworth, MD, Brian Link, Thomas P. Miller, MD, Hildy Dillon, MPH, Jonathan W. Friedberg, MD

Blood (2010) 116 (21): 1768.

https://doi.org/10.1182/blood.V116.21.1768.1768

Published: 2010

Journal Articles

Elevation of Serum Free Light Chains Are Common In Lymphoma and Associated with Poor Event Free and Overall Survival

Matthew J Maurer, James Cerhan, MD, PhD, Jerry A Katzmann, PhD, Brian Link, Ivana N Micallef, MD, Joseph Colgan, MD, Thomas M. Habermann, MD, David James Inwards, MD, Svetomir Markovic, MD, PhD, Stephen M. Ansell, MD, PhD, Luis Porrata, MD, Patrick B Johnston, MD, Grzegorz S. Nowakowski, MD, Carrie A Thompson, MD, Mamta Gupta, Ph.D, Sergei I Syrbu, MD, Paul Kurtin, MD, William Macon, MD, Thomas E. Witzig, MD

Blood (2010) 116 (21): 4136.

https://doi.org/10.1182/blood.V116.21.4136.4136

Published: 2010

Journal Articles

Expression of Interferon Regulatory Factor-4 (IRF4/MUM1) Is Associated with Inferior Overall Survival In Peripheral T-Cell Lymphoma

Andrew L Feldman, MD, Ahmet Dogan, MD, PhD, Matthew J Maurer, Thomas M Habermann, MD, Patrick B Johnston, MD, PhD, Thomas E. Witzig, MD, Susan Slager, PhD, James Cerhan, MD, PhD, Stephen M. Ansell, MD, PhD

Blood (2010) 116 (21): 140.

https://doi.org/10.1182/blood.V116.21.140.140

Published: 2010

Journal Articles

Pretreatment Serum Cytokines Predict Early Disease Relapse and a Poor Prognosis In Diffuse Large B-Cell Lymphoma (DLBCL) Patients

Stephen M. Ansell, MD, PhD, Matthew J Maurer, Steven C Ziesmer, Susan L Slager, PhD, Thomas M Habermann, MD, Brian Link, Thomas E Witzig, MD, James Cerhan, MD, PhD, Anne J. Novak, PhD

Blood (2010) 116 (21): 991.

https://doi.org/10.1182/blood.V116.21.991.991

Published: 2010

Journal Articles

A BAFF-R Mutation Associated with Non-Hodgkin Lymphoma Exhibits Altered TRAF Binding and Reveals New Insights Into Proximal BAFF-R Signaling

Joanne M. Hildebrand, PhD, Zhenghua Luo, Michelle Manske, Steven Ziesmer, Tammy Price-troska, Wai Lin, Bruce Hostager, PhD, Susan Slager, PhD, Thomas E. Witzig, MD, Stephen M. Ansell, MD, PhD, James Cerhan, MD, PhD, Gail Bishop, PhD, Anne J. Novak, PhD

Blood (2010) 116 (21): 468.

https://doi.org/10.1182/blood.V116.21.468.468

Published: 2010

Journal Articles

Family-Associated Monoclonal B Lymphocytosis Is Commonly Oligoclonal and Expresses Markers Associated with Adverse Risk in CLL

Mark C Lanasa, MD, PhD, Sallie D Allgood, MS, Susan L. Slager, PhD, Nicola Camp, PhD, Logan Spector, PhD, Laura Rassenti, PhD, Neil E. Kay, Jon P Gockerman, MD, Alicia Volkheimer, MS, Barbara K Goodman, PhD, Sara Strom, PhD, Timothy Call, MD, James Cerhan, MD, PhD, Jose F Leis, MD, PhD, Lynn Goldin, PhD, Gerald Marti, MD, PhD, J Brice Weinberg, MD, Neil Caporaso, MD, Marc C. Levesque, MD, PhD

Blood (2008) 112 (11): 3144.

https://doi.org/10.1182/blood.V112.11.3144.3144

Published: 2008

NARROW

Treatment Patterns and Outcomes of DLBCL after Failure of Front-Line Immunochemotherapy

Study of the Subclonal Mutations in Primary Diffuse Large B-Cell Lymphoma

Disease Progression and Complications Are the Main Cause of Death in Patients with Chronic Lymphocytic Leukemia (CLL) Independent of Age and Comorbidities at Diagnosis

Incidence and Outcomes of Treatment Refractory Diffuse Large B-Cell Lymphoma in the Immunochemotherapy Era

Natural History of Central Nervous System Relapse in Diffuse Large B Cell Lymphoma in the Immunochemotherapy Era

Event-Free Survival at 12 Months and Subsequent Overall Survival in Patients with Peripheral T-Cell Lymphoma

Investigation of CLL-Susceptibility Loci with Monoclonal B-Cell Lymphocytosis (MBL) Risk and Confirmation of Recently Reported CLL-Susceptibility Loci

Vitamin D Insufficiency and Prognosis In Chronic Lymphocytic Leukemia (CLL)

Monoclonal and Polyclonal Serum Free Light Chains and Clinical Outcome In Chronic Lymphocytic Leukemia

Does An Anthracycline Make a Difference for Follicular Lymphoma (FL) Grade 3? Patterns of Care and Treatment Outcomes of Grade 3 FL From the National LymphoCare Study (NLCS)

Elevation of Serum Free Light Chains Are Common In Lymphoma and Associated with Poor Event Free and Overall Survival

Expression of Interferon Regulatory Factor-4 (IRF4/MUM1) Is Associated with Inferior Overall Survival In Peripheral T-Cell Lymphoma

Pretreatment Serum Cytokines Predict Early Disease Relapse and a Poor Prognosis In Diffuse Large B-Cell Lymphoma (DLBCL) Patients

A BAFF-R Mutation Associated with Non-Hodgkin Lymphoma Exhibits Altered TRAF Binding and Reveals New Insights Into Proximal BAFF-R Signaling

Family-Associated Monoclonal B Lymphocytosis Is Commonly Oligoclonal and Expresses Markers Associated with Adverse Risk in CLL

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only